RUNX2 and breast carcinoma: For the purpose, we conducted multifaceted analyses both in vitro and in vivo to verify the dysfunction and the concomitant mechanism of RUNX2 in modulating proliferation, migration, invasion, and chemoresistance of breast cancer cells.